Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-12-24FDA Approved: EXEMESTANE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Exemestane submitted by Mylan Pharmaceuticals Inc., indicating approval of a generic Exemest…
-
CLINICAL_TRIALS trial_result · 2008-12-18Clinical Trial Update: Adjuvant Post-Tamoxifen Exemestane Trial [Phase 3]
Phase 3 adjuvant exemestane trial following tamoxifen for breast cancer has been terminated.
-
CLINICAL_TRIALS research · 2008-12-16Clinical Trial Update: Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women [Phase 3]
This clinical trial update describes a Phase 3 randomized study evaluating hCG-A for prevention of breast cancer in high-risk women; current…
-
CLINICAL_TRIALS research · 2008-12-11Clinical Trial Update: Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants [Phase 1, Phase 2]
A completed Phase 1/Phase 2 clinical trial evaluating whether tailored reports reduce anxiety in cancer patients and their confidants, spons…
-
FDA approval · 2008-12-10FDA Approved: ARIMIDEX — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for ARIMIDEX (anastrozole) submitted by ANI Pharmaceuticals, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-12-10Clinical Trial Update: The Role of Serotonin in Hot Flashes After Breast Cancer [NA]
This clinical trial update discusses the role of serotonin in hot flashes after breast cancer and notes that results were posted in 2008.
-
CLINICAL_TRIALS trial_result · 2008-12-04Clinical Trial Update: Yoga to Reduce Cancer Fatigue [Phase 2]
A Phase 2 clinical trial update indicates the study assessing yoga to reduce cancer-related fatigue in breast cancer patients has completed.…
-
CLINICAL_TRIALS trial_result · 2008-11-26Clinical Trial Update: A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer [Phase 2]
This Phase 2 trial assesses a preoperative combination of gemcitabine, epirubicin, and paclitaxel in locally advanced breast cancer; the stu…
-
CLINICAL_TRIALS trial_result · 2008-11-26Clinical Trial Update: A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies. [Phase 2]
A Phase 2 study evaluated SU11248 (sunitinib malate) in patients with metastatic breast cancer who had failed other therapies; the trial has…
-
CLINICAL_TRIALS trial_result · 2008-11-25Clinical Trial Update: Light Based Analysis of Developing Breast Tissue in Adolescent Girls: a Feasibility Study
A completed feasibility trial evaluating a light-based analysis method applied to developing breast tissue in adolescent girls. The study li…
-
CLINICAL_TRIALS trial_result · 2008-11-19Clinical Trial Update: Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Docetaxel (ADoc) in Breast Cancer [Phase 3]
A Phase 3 neoadjuvant trial in primary breast cancer compared AC-Doc (doxorubicin/cyclophosphamide followed by docetaxel) with dose-dense do…
-
CLINICAL_TRIALS trial_result · 2008-11-14Clinical Trial Update: Venlafaxine for Hot Flashes After Breast Cancer [Phase 2]
This is a Phase 2 trial evaluating venlafaxine for hot flashes in breast cancer patients, and the study has completed.
-
CLINICAL_TRIALS trial_result · 2008-11-04Clinical Trial Update: Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin®) in Advanced Breast Carcinoma [Phase 2]
Phase 2 trial evaluating Vinorelbine and Oxaliplatin (Vinox) with or without Trastuzumab (Herceptin) in advanced breast cancer was terminate…
-
CLINICAL_TRIALS trial_result · 2008-10-24Clinical Trial Update: PV-10 Chemoablation of Recurrent Breast Carcinoma [Phase 1]
A Phase 1 trial evaluating PV-10 chemoablation for recurrent breast carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2008-10-21Clinical Trial Update: Phase IB/II Trial Combining Vinorelbine With Sorafenib as First-Line Treatment in Patients With Metastatic Breast Cancer [Phase 1, Phase 2]
This update describes a Phase 1/2 trial evaluating the combination of vinorelbine and sorafenib as first-line therapy for metastatic breast …
-
CLINICAL_TRIALS trial_result · 2008-10-20Clinical Trial Update: Androgen Therapy for Management of Estrogen/Progesterone Receptor Negative ER(-)PR(-) Metastatic Breast Cancer [Phase 2]
Phase 2 trial of androgen therapy for ER-/PR- metastatic breast cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2008-10-16Clinical Trial Update: Irinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and Capecitabine [Phase 2]
A Phase 2 trial of irinotecan in patients with advanced/metastatic breast cancer after failure of an anthracycline, a taxane, and capecitabi…
-
CLINICAL_TRIALS trial_result · 2008-10-08Clinical Trial Update: Vaccination Against High Risk Breast Cancer Using Tumor Derived Heat Shock Protein 70 [Phase 1, Phase 2]
Phase 1/2 trial of a tumor-derived heat shock protein 70 vaccine for breast cancer has been terminated.
-
CLINICAL_TRIALS research · 2008-10-08Clinical Trial Update: Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage
This feasibility study evaluating ductal lavage in breast cancer patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2008-09-29Clinical Trial Update: A Study to Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast Cancer [Phase 4]
A Phase 4 trial evaluated the safety of adjuvant exemestane after prior tamoxifen in postmenopausal women with estrogen receptor-positive pr…
-
CLINICAL_TRIALS trial_result · 2008-09-25Clinical Trial Update: Soy, Selenium and Breast Cancer Risk [NA]
A completed University of East Anglia trial investigated whether soy and selenium influence breast cancer risk.
-
CLINICAL_TRIALS trial_result · 2008-09-25Clinical Trial Update: Tamoxifen Pharmacogenetics and Clinical Effects
Update on a completed clinical trial investigating how genetic variation affects tamoxifen pharmacokinetics and clinical effects in breast c…
-
CLINICAL_TRIALS trial_result · 2008-09-25Clinical Trial Update: Aromatase Inhibitor Clinical Trial
An aromatase inhibitor clinical trial in breast cancer sponsored by the National Institute of General Medical Sciences has an unknown status…
-
CLINICAL_TRIALS withdrawal · 2008-09-23Clinical Trial Update: Study of Amrubicin With or Without Herceptin in Patients With Metastatic Breast Cancer [Phase 2]
A Phase 2 trial of amrubicin with or without Herceptin for metastatic breast cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2008-09-17Clinical Trial Update: A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy [Phase 1]
Phase 1 study evaluating the safety and feasibility of taking celecoxib between biopsy and lumpectomy/mastectomy in women with early breast …